Cryo-electron microscopy structure of the Mycobacterium tuberculosis cytochrome bcc:aa₃ supercomplex and a novel inhibitor targeting subunit cytochrome cI

• Main Authors: Mathiyazakan, Vikneswaran, Wong, Chui Fann, Harikishore, Amaravadhi, Pethe, Kevin, Grüber, Gerhard
• 其他作者: School of Biological Sciences
• 格式: Article
• 語言: English
• 出版: 2023
• 主題: Science::Biological sciences::Biophysics; Science::Biological sciences::Biochemistry; Cytochrome bcc:aa3 Oxidase; Bioenergetics; OXPHOS; Tuberculosis; Mycobacterium Tuberculosis; Inhibitor
• 在線閱讀: https://hdl.handle.net/10356/169212
• 機構: Nanyang Technological University

The mycobacterial cytochrome bcc:aa3 complex deserves the name “super-complex” since it combines three cytochrome oxidases—cytochrome bc,cytochromec, and cytochrome aa3—into one supramolecular machine and performs electron transfer for the reduction of oxygen to water and proton transport to generate the proton motive force for ATP synthesis. Thus, the bcc:aa3 complex represents a valid drug target for Mycobacterium tuberculosis infections. The production and purification of an entire M. tuberculosis cytochrome bcc:aa3 are fundamental for biochemical and structural charac- terization of this supercomplex, paving the way for new inhibitor targets and molecules. Here,weproducedandpurified the entire and active M. tuberculosis cyt-bcc:aa3 oxidase, as demonstrated by the different heme spectra and an oxygen consumption assay. The resolved M. tuberculosis cyt-bcc:aa3 cryo-electron microscopy structure reveals a dimer with its functional domains involved in electron, proton, oxygen transfer, and oxygen reduction. The structure shows the two cytochrome cIcII head domains of the dimer, thecounterpart of the soluble mitochondrial cytochrome c, in a so-called “closed state,” in which electrons are translocated from the bcc to the aa3 domain. The structural and mechanistic insights provided the basis for a virtual screening campaign that identified a potent M. tuberculosis cyt-bcc:aa3 inhibitor, cytMycc1. cytMycc1 targets the mycobac- terium-specific a3-helix of cytochrome cI and interferes with oxygen consumption by interrupting electron translocation via the cIcII head. The successful identification of anew cyt-bcc:aa3 inhibitor demonstrates the potential of a structure-mechanism-based approach for novel compound development.